Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine

Pediatric Infectious Disease Journal

Volumn 29, Issue 1, 2010, Pages 1-5

  Belongia, Edward A ^a   Irving, Stephanie A ^a   Shui, Irene M ^b   Kulldorff, Martin ^b   Lewis, Edwin ^c   Yin, Ruihua ^b   Lieu, Tracy A ^b,d   Weintraub, Eric ^e   Yih, W Katherine ^b   Li, Rong ^b   Baggs, James ^e  

^a MARSHFIELD CLINIC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KAISER PERMANENTE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Humans; Infant; Intussusception epidemiology; Prospective studies; Rotavirus vaccines adverse effects; Vaccination adverse effects

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ENCEPHALITIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRAM NEGATIVE SEPSIS; HUMAN; INFANT; INFECTION PREVENTION; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGITIS; MORBIDITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; PRIORITY JOURNAL; RISK ASSESSMENT; ROTAVIRUS; SEIZURE; VIRUS INFECTION;

EID: 74049152982     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181af8605     Document Type: Article

References (24)

1. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565-572.
2. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. American Academy of Pediatrics. Pediatrics. 1998;102:1483-1491.
3. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR. 1999;48:1007.
4. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. MMWR. 1999; 48: 577-581.
5. Kramarz P, France EK, Destefano F, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J. 2001;20: 410-416.
6. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564-572.
7. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33. (Pubitemid 43048948)
8. Chen RT, DeStefano F, Davis RL, et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ. 2000;78:186-194.
9. DeStefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf. 2001;10:403-406.
10. Lieu TA, Kulldorff M, Davis RL, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45(10 suppl 2):S89-S95.
11. Kulldorff M, Davis RL, Kolczak M, et al. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Int J Biostat. In press. Available at: http://www.dacp.org/MaxSPRTsubm.pdf. Accessed October 21, 2009.
12. Bines JE, Kohl KS, Forster J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22: 569-574.
13. Grech V, Calvagna V, Falzon A, et al. Fatal, rotavirus-associated myocarditis and pneumonitis in a 2-year-old boy. Ann Trop Paediatr. 2001;21: 147-148.
14. Kehle J, Metzger-Boddien C, Tewald F, et al. First case of confirmed rotavirus meningoencephalitis in Germany. Pediatr Infect Dis J. 2003;22: 468-470.
15. Lowenthal A, Livni G, Amir J, et al. Secondary bacteremia after rotavirus gastroenteritis in infancy. Pediatrics. 2006;117:224-226.
16. Nakagomi T, Nakagomi O. Rotavirus antigenemias in children with en-cephalopathy accompanied by rotavirus gastroenteritis. Arch Virol. 2005; 150:1927-1931.
17. Schumacher RF, Forster J. The CNS symptoms of rotavirus infections under the age of two. Klin Padiatr. 1999;211:61-64.
18. Haber P, Chen RT, Zanardi LR, et al. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone? Pediatrics. 2004;113:e353-e359.
19. Fischer TK, Bihrmann K, Perch M, et al. Intussusception in early childhood: a cohort study of 1.7 million children. Pediatrics. 2004;114:782-785.
20. Parashar UD, Holman RC, Cummings KC, et al. Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics. 2000; 106:1413-1421.
21. Wald A. Sequential tests of statistical hypotheses. Ann Math Stat. 1945;16: 117-186.
22. Mullooly J, Drew L, DeStefano F, et al. Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety Dat-alink Team. Am J Epidemiol. 1999;149:186-194.
23. Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008;121:1206-1212.
24. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR Morb Mortal Wkly Rep. 2008;57:258-260.